Volume 7, Issue 6, Pages (June 2008)

Slides:



Advertisements
Similar presentations
Volume 14, Issue 2, Pages (August 2011)
Advertisements

Volume 9, Issue 3, Pages (March 2009)
Volume 1, Issue 2, Pages (February 2005)
Volume 3, Issue 3, Pages (March 2006)
Beneficial Effects of Subcutaneous Fat Transplantation on Metabolism
Volume 8, Issue 4, Pages (October 2008)
Volume 137, Issue 6, Pages e2 (December 2009)
Volume 3, Issue 5, Pages (May 2006)
Volume 16, Issue 10, Pages (September 2016)
Volume 20, Issue 4, Pages (October 2014)
Volume 26, Issue 2, Pages e3 (August 2017)
Ling Yang, Ping Li, Suneng Fu, Ediz S. Calay, Gökhan S. Hotamisligil 
Volume 11, Issue 5, Pages (May 2010)
Volume 22, Issue 6, Pages (December 2015)
Ludger Scheja, Joerg Heeren  Journal of Hepatology 
Grzegorz Sumara, Olga Sumara, Jason K. Kim, Gerard Karsenty 
Beneficial Effects of Subcutaneous Fat Transplantation on Metabolism
Volume 18, Issue 2, Pages (August 2013)
Volume 6, Issue 3, Pages (September 2007)
Volume 18, Issue 5, Pages (November 2013)
Volume 14, Issue 6, Pages (December 2011)
Volume 21, Issue 11, Pages (December 2017)
Volume 41, Issue 6, Pages (December 2014)
Volume 17, Issue 5, Pages (May 2013)
Volume 7, Issue 3, Pages (March 2008)
Volume 7, Issue 6, Pages (June 2008)
Volume 10, Issue 5, Pages (November 2009)
IKKɛ: A Bridge between Obesity and Inflammation
Volume 19, Issue 1, Pages (January 2014)
Volume 24, Issue 3, Pages (September 2016)
Volume 20, Issue 1, Pages (July 2014)
“De-liver-ance” From CB1: A Way to Counteract Insulin Resistance?
Volume 7, Issue 6, Pages (June 2008)
Protection against High-Fat-Diet-Induced Obesity in MDM2C305F Mice Due to Reduced p53 Activity and Enhanced Energy Expenditure  Shijie Liu, Tae-Hyung.
Volume 14, Issue 10, Pages (March 2016)
Heat Shock Transcription Factor 1 Is a Key Determinant of HCC Development by Regulating Hepatic Steatosis and Metabolic Syndrome  Xiongjie Jin, Demetrius.
Critical Role for Hypothalamic mTOR Activity in Energy Balance
Volume 23, Issue 6, Pages (June 2016)
Volume 9, Issue 5, Pages (May 2009)
Volume 16, Issue 3, Pages (September 2012)
Volume 127, Issue 3, Pages (September 2004)
Volume 10, Issue 5, Pages (November 2009)
Volume 23, Issue 4, Pages (April 2016)
Volume 4, Issue 1, Pages (July 2006)
Volume 25, Issue 4, Pages e4 (April 2017)
Volume 14, Issue 1, Pages (July 2011)
Volume 5, Issue 5, Pages (May 2007)
Volume 1, Issue 4, Pages (April 2005)
Varman T. Samuel, Gerald I. Shulman  Cell Metabolism 
Volume 22, Issue 2, Pages (August 2015)
Volume 6, Issue 1, Pages (July 2007)
Prevention of Steatosis by Hepatic JNK1
Volume 14, Issue 5, Pages (November 2011)
Volume 23, Issue 1, Pages (January 2016)
Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice  Decheng Ren, Minghua Li, Chaojun Duan, Liangyou.
Volume 14, Issue 2, Pages (August 2011)
Volume 22, Issue 2, Pages (August 2015)
Ann Marie Schmidt, Kathryn J. Moore  Cell Metabolism 
Lipin, a lipodystrophy and obesity gene
Tissue Immunometabolism: Development, Physiology, and Pathobiology
Volume 4, Issue 5, Pages (November 2006)
Volume 7, Issue 4, Pages (May 2014)
Volume 137, Issue 6, Pages e2 (December 2009)
Volume 5, Issue 6, Pages (June 2007)
Macrophages, Immunity, and Metabolic Disease
Volume 147, Issue 4, Pages (November 2011)
Loss of Adipose Growth Hormone Receptor in Mice Enhances Local Fatty Acid Trapping and Impairs Brown Adipose Tissue Thermogenesis  Liyuan Ran, Xiaoshuang.
Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in Mice  Jun Yoshino, Kathryn F. Mills,
Volume 3, Issue 3, Pages (March 2006)
Volume 26, Issue 1, Pages 1-10.e7 (January 2019)
Presentation transcript:

Volume 7, Issue 6, Pages 496-507 (June 2008) Alternative M2 Activation of Kupffer Cells by PPARδ Ameliorates Obesity-Induced Insulin Resistance  Justin I. Odegaard, Roberto R. Ricardo-Gonzalez, Alex Red Eagle, Divya Vats, Christine R. Morel, Matthew H. Goforth, Vidya Subramanian, Lata Mukundan, Anthony W. Ferrante, Ajay Chawla  Cell Metabolism  Volume 7, Issue 6, Pages 496-507 (June 2008) DOI: 10.1016/j.cmet.2008.04.003 Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 1 PPARδ Regulates Expression of Arginase 1 in Alternatively Activated Macrophages (A–C) Decreased levels of arginase 1 (Arg1) mRNA (A), protein (B), and enzymatic activity (C) in IL-4-stimulated PPARδ−/− (Ppard−/−) bone marrow-derived macrophages (BMDMs). (D) Activation of the Arg1 promoter by PPARδ/RXR heterodimers and IL-4. Deletion of the PPAR response element in the arginase 1 enhancer abolishes transcriptional activation by PPARδ and IL-4. (E and F) Attenuated induction of arginase 1 in PPARδ/γ double-knockout macrophages. (E) Real-time analysis of PPARδ and PPARγ expression in BMDMs generated from control, macrophage-specific PPARδ−/− (Mac-PPARδ−/−), and Mac-PPARδ/γ−/− mice. Primers specific for exon 4 of PPARδ or exon 1 of PPARγ were used to quantify excision efficiency in BMDMs. ND, not detected. (F) qRT-PCR analysis of Arg1 mRNA in various genotypes. Data are presented as mean ± SEM. ∗p < 0.05; ∗∗p < 0.01. Cell Metabolism 2008 7, 496-507DOI: (10.1016/j.cmet.2008.04.003) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 2 PPARδ Is Required for Expression of the Immune Phenotype of Alternative Macrophage Activation (A) Decreased expression of markers of alternative activation in IL-4-stimulated PPARδ−/− BMDMs. Relative expression of alternative activation mRNAs was quantified by qRT-PCR. Retnla, resistin-like α; Mrc1, mannose receptor; Chi3l3, chitinase 3-like 3; Pdcd1lg2, programmed cell death 1 ligand 2. (B and C) PPARδ is required for suppression of IL-6 (B) and IL-12 (C) production in alternatively activated BMDMs. (D) PPARδ is required for the mitogenic response to IL-4 in BMDMs. Data are presented as mean ± SEM. ∗p < 0.05; ∗∗p < 0.01. Cell Metabolism 2008 7, 496-507DOI: (10.1016/j.cmet.2008.04.003) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 3 Conjugated Oleic Acid Potentiates Alternative Macrophage Activation (A) Oleic acid potentiates IL-4 induction of arginase activity in wild-type, but not PPARδ−/−, BMDMs. (B–E) PPARδ is required for potentiation of alternative activation by oleic acid. BMDMs from 129/SvJ wild-type and PPARδ−/− mice were stimulated with IL-4 for 48 hr in the presence of BSA or BSA:oleic acid conjugate. qRT-PCR analyses were performed on mRNAs for Arg1 (B), Clec7a (dectin-1) (C), Pdcd1lg2 (D), and Chi3l3 (E). Data are presented as mean ± SEM. ∗p < 0.05; ∗∗p < 0.01. Cell Metabolism 2008 7, 496-507DOI: (10.1016/j.cmet.2008.04.003) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 4 Hematopoietic Deficiency of PPARδ Exacerbates Insulin Resistance and Impairs Glucose Tolerance (A) Oral glucose tolerance tests (1 g/kg) were carried out after 18 weeks of high-fat diet in male mice reconstituted with wild-type or PPARδ−/− bone marrow (WT BMT and PPARδ−/− BMT, respectively) (n = 5–7 per cohort). (B) Insulin tolerance tests (0.65 U/kg) were performed in obese mice after a 4 hr fast (n = 5–7 per cohort). Similar results were obtained in two other cohorts of transplanted mice (n = 7 per group). (C) Fasting serum levels of insulin in WT BMT and PPARδ−/− BMT mice after a 5 hr fast. (D–F) Impairment in insulin action in PPARδ−/− BMT mice. Total cell lysates were immunoblotted for phospho-Akt (pAkt) or total Akt in liver (D), quadriceps muscle (E), and epididymal white adipose tissue (WAT) (F). (G and H) Mitochondrial dysfunction in peripheral tissues of PPARδ−/− BMT mice. Relative transcript levels for genes encoding key enzymes in β-oxidation and oxidative phosphorylation (OXPHOS) and transcriptional regulators controlling these pathways in liver (G) and quadriceps (H) are shown. Data are presented as mean ± SEM. ∗p < 0.05; ∗∗p < 0.01. Cell Metabolism 2008 7, 496-507DOI: (10.1016/j.cmet.2008.04.003) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 5 Increased Adiposity in PPARδ−/− BMT Mice (A) Body composition was quantified by dual-energy X-ray absorptiometry (DEXA) in weight-matched transplanted mice (n = 7 per cohort). (B) Representative images of necropsied WT BMT and PPARδ−/− BMT mice after 22 weeks of high-fat diet. (C) Increased epididymal fat pad mass in PPARδ−/− BMT mice (n = 5 per cohort). (D) Increased adipocyte cell size in PPARδ−/− BMT mice. Adipocyte cell size was measured using dark-field images. (E and F) Macrophage content and activation in WAT. (E) Adipose tissue macrophage (ATM) content was determined by immunostaining for the macrophage antigen F4/80. p = 0.16 by paired t test; n = 4 per cohort. (F) Interrogation of ATM activation state by qRT-PCR. Emr1, F4/80; Cd68, macrosialin; Jag1, jagged 1; Il1rn, IL-1 receptor antagonist; Il4ra, IL-4 receptor α; Nos2, inducible nitric oxide synthase; Tnfa, tumor necrosis factor α; Il6, interleukin-6. Data are presented as mean ± SEM. ∗p < 0.05; ∗∗p < 0.01. Cell Metabolism 2008 7, 496-507DOI: (10.1016/j.cmet.2008.04.003) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 6 Impaired Alternative Activation of Kupffer Cells and Hepatic Dysfunction in PPARδ−/− BMT Mice (A) Decreased expression of signature genes for alternative activation of macrophages in PPARδ−/− BMT livers (n = 5–7 per cohort). (B) Reduction in liver arginase activity in PPARδ−/− BMT mice (n = 5–7 per cohort). (C) IL-4 is unable to induce alternative activation of Kupffer cells in PPARδ−/− mice (n = 4 per cohort). Tgfb1, transforming growth factor β1. (D and E) Treatment of primary hepatocytes with macrophage conditioned medium (CM) alters their oxidative metabolism. CM from PPARδ−/− macrophages suppresses oxidative metabolism as monitored by β-oxidation of fatty acids (D) and expression of fatty acid oxidation and OXPHOS genes (E). (F and G) Histologic (F) and biochemical (G) evidence of increased triglyceride accumulation in livers of PPARδ−/− BMT mice. Data are presented as mean ± SEM. ∗p < 0.05; ∗∗p < 0.01. Cell Metabolism 2008 7, 496-507DOI: (10.1016/j.cmet.2008.04.003) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 7 Model Highlighting the Metabolic Functions of Alternatively Activated Macrophages PPARγ transcriptional signaling is required for maturation of macrophages in adipose tissue, whereas PPARδ controls the expression of the alternative phenotype in Kupffer cells of obese mice. Two potential mechanisms by which alternatively activated macrophages may improve insulin action in obese mice are (1) paracrine inhibition of inflammation and (2) secretion of trophic factors that can directly modulate oxidative metabolism in parenchymal cells (small arrows). Cell Metabolism 2008 7, 496-507DOI: (10.1016/j.cmet.2008.04.003) Copyright © 2008 Elsevier Inc. Terms and Conditions